first_imgnarvikk/iStockBy MORGAN WINSOR, ERIN SCHUMAKER and IVAN PEREIRA, ABC News(NEW YORK) — A pandemic of the novel coronavirus has now infected more than 63.7 million people and killed over 1.4 million worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.Here’s how the news is developing Wednesday. All times Eastern:Dec 02, 7:42 amOperation Warp Speed’s chief science adviser hopes Pfizer/BioNTech vaccine is approved next weekDr. Moncef Slaoui, chief science adviser to Operation Warp Speed, said he expects the U.S. Food and Drug Administration “to reach a similar conclusion” to the United Kingdom’s approval of a COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech.“I hope by the 10th or 11th of December the Pfizer vaccine is approved,” Slaoui told ABC News chief anchor George Stephanopoulos in an interview Wednesday on Good Morning America.Slaoui urged Americans to “listen to the experts” and trust the vaccine approval process.“No corners have been cut,” he said. “The [vaccine] development has been done very quickly because we had great science to allow us to do all the discovery work in weeks rather than in years. And then the clinical work, the most important part that demonstrates the effectiveness of the vaccine and its safety, has been done to a higher standard than what’s done normally in larger number of people but will be assessed and studied in an ongoing basis.”Slaoui described a vaccine as “an insurance against this virus.”“This is what will get us out of the pandemic,” he said.Dec 02, 4:54 amUS reports over 180,000 new casesThere were 180,098 new cases of COVID-19 confirmed in the United States on Tuesday, according to a real-time count kept by Johns Hopkins University.It’s the 29th straight day that the country has reported over 100,000 newly diagnosed infections. Tuesday’s count is down from a peak of 205,557 new cases last Friday.An additional 2,597 fatalities from COVID-19 were also registered nationwide on Tuesday, just under the all-time high of 2,609 new deaths on April 15.COVID-19 data may be skewed in the coming days and weeks due to possible lags in reporting over Thanksgiving followed by a potentially very large backlog from the holiday.A total of 13,725,917 people in the United States have been diagnosed with COVID-19 since the pandemic began, and at least 270,669 of them have died, according to Johns Hopkins. The cases include people from all 50 U.S. states, Washington, D.C. and other U.S. territories as well as repatriated citizens.Much of the country was under lockdown by the end of March as the first wave of pandemic hit. By May 20, all U.S. states had begun lifting stay-at-home orders and other restrictions put in place to curb the spread of the novel coronavirus. The day-to-day increase in the country’s cases then hovered around 20,000 for a couple of weeks before shooting back up over the summer.The numbers lingered around 40,000 to 50,000 from mid-August through early October before surging again to record levels, crossing 100,000 for the first time on Nov. 4 and reaching 200,000 for the first time on Nov. 27.Dec 02, 3:44 amUK authorizes Pfizer/BioNTech vaccine, rollout to begin next weekA COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech has been approved for use in the United Kingdom.The U.K. Department of Health and Social Care announced Wednesday that it has accepted the recommendation from the country’s drug regulator to grant a temporary authorization for emergency use of the Pfizer/BioNTech vaccine, called BNT162b2. The Medicines and Healthcare products Regulatory Agency (MHRA) concluded that the vaccine met its standards of safety, quality and effectiveness.“The vaccine will be made available across the U.K. from next week,” a Department of Health and Social Care spokesperson said in a statement, adding that the National Health Service, the publicly-funded healthcare system, “will begin putting their extensive preparations into action to provide care and support to all those eligible for vaccination.”The United Kingdom is the first country in the world to approve the Pfizer/BioNTech vaccine. The companies said in a joint press release Wednesday that they are anticipating further regulatory decisions across the globe in the coming days and weeks and are ready to deliver vaccine doses pending authorizations or approvals.“Today’s Emergency Use Authorization in the U.K. marks a historic moment in the fight against COVID-19,” Pfizer chairman and CEO Albert Bourla said in a statement. “As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world. With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.”The MHRA made its recommendation based on a rolling submission, including data from the Phase 3 trial which demonstrated a vaccine efficacy rate of 95%. The Pfizer/BioNTech vaccine was generally well tolerated, with no serious safety concerns reported to date.Pfizer and BioNTech had already agreed to supply the United Kingdom with 40 million doses of BNT162b2 once authorized for emergency use. Now that the vaccine is authorized, the companies will immediately begin delivering doses, the first of which are expected to arrive on U.K. soil in the coming days. The rest of the doses will arrive in stages, with complete delivery fulfillment expected in 2021, according to the press release.Pfizer and BioNTech said the distribution of their vaccine in the United Kingdom will be prioritized according to the populations identified in guidance from the Joint Committee on Vaccination and Immunisation, an independent expert group that advises the U.K. government on immunization.“The Emergency Use Authorization in the U.K. will mark the first time citizens outside of the trials will have the opportunity to be immunized against COVID-19,” BioNTech CEO and co-founder Ugur Sahin said in a statement. “We believe that the roll-out of the vaccination program in the U.K. will reduce the number of people in the high-risk population being hospitalized.”The companies have also filed a request for emergency use authorization with the U.S. Food and Drug Administration and have submitted an application for conditional marketing authorization with the European Medicines Agency.Copyright © 2020, ABC Audio. All rights reserved.last_img read more

first_img“It is unclear why no one has come forward to hold the post of chair or vice-chair.“The College noted that changes to some exam timetables may have been a contributing factor in the lack of applications.“The College has pointed out that the common rooms can apply again next January for a ball in June 2020.”Cherwell understands that a number of freshers were originally interested in smaller roles, as opposed to taking on responsibility for an event as notable as a Commemoration Ball.Speaking of the prospect of a smaller ball in 2019, Randall told students in her earlier message: “If you were one of those people, this Ball would involve less responsibility and thus might suit you.”JCR President Calla Randall did not respond to Cherwell’s request for comment.This article was updated Friday 6 April (17.45pm) to include the Magdalen JCR President’s second message to undergraduates, confirming the ball would definitely be cancelled. Magdalen College has scrapped its Commemoration Ball, due to be held at the College next year.In an email to undergraduate students, seen by Cherwell, JCR President Calla Randall wrote that the Ball “has been cancelled due to a lack of applications for Chairman, Vice-Chairman, and Treasurer.”Magdalen’s Commemoration Ball was also previously cancelled in 2015.A first-year Magdalen student told Cherwell: “It’s a shame, but if there’s no one willing to put themselves forward for ball committee then there’s not really much we can do.”Magdalen College’s freshers have been criticised on the Oxfess Facebook platform for not applying to fill organising roles.One Oxfess read: “Magdalen freshers why did none of you apply for ball committee you selfish little shits.” In her announcement to fellow undergraduates, JCR President Calla Randall wrote: “The MCR President and I did try our best to advertise this opportunity so we’re disappointed that the Ball will not go ahead.“There will be an opportunity for the next JCR and MCR Presidents to request a ball in 2020 next academic year.”A smaller black-tie event was held in 2015 when that year’s ball was cancelled.Randall told students: “Thus, there is precedent for event [sic] to take place in 2019, although there is some resistance from College to repeat this.“However, if – together with the MCR – a group were to put together a detailed plan for how this might work, referencing similar events at other Colleges, I think it would be possible to convince College otherwise.”However, in a later message to JCR members, obtained by Cherwell on 6 April, Randall confirmed that the ball was “definitely cancelled.”She wrote: “Despite working hard with the MCR President to persuade College to reopen applications for the Commemoration Ball committee, it is clear that they are unwilling to change their position.“College argues that we are now too far behind schedule to manage a successful Ball.”She again cited a lack of applications for the main management positions as the ultimate reason for the cancellation.Magdalen College Home Bursar, Mark Blandford-Baker, told Cherwell: “Commemoration Balls are substantial undertakings and organised by students primarily for students, albeit with extensive administrative support from the College.last_img read more

first_imgAnuga Trade Fair takes place at Koelnmesse, in Cologne on 8-12 October, with one whole hall given over to bakery.PS8, run by Sandra Sullivan, will support British exhibitors and organise the UK pavilion. UK bakery exhibitors include Artisan Biscuits, Honeytop Speciality Foods, Perfection Foods, Rosario Exports (The British Pantry), The Handmade Cake Company, Walkers Shortbread and Yum Yum Brothers.Koelnmesse vice-president of food business Peter Grothues said: “There will be 6,500 exhibitors from around 100 countries at the show. I look forward to welcoming British exhibitors and visitors.”To find out more, visit www.anuga.com.last_img